Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease

키워드

참고문헌 (100)

1. Sant GR, "The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis", Urology, 69(4 Suppl), pp.34~40 (2007)
2. Keay S, "Cell signaling in interstitial cystitis", painful bladder syndrome, 2008, pp.20, 2174~2179
3. Homma Y, "Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome", Int J Urol, 16, pp.597~615 (2009)
4. Homma Y, "Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015", Int J Urol, 23, pp.542~549 (2016)
5. Shie JH, "Higher levels of cell apoptosis and abnormal Ecadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis", painful bladder syndrome, 2011, pp.108(2 Pt 2), E136~E141
6. Southgate J, "Differentiation potential of urothelium from patients with benign bladder dysfunction", BJU Int, 99, pp.1506~1516 (2007)
7. Zeng Y, "Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis", J Urol, 178(4 Pt 1), pp.1322~1327 (2007)
8. Hauser PJ, "Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis", J Urol, 179, pp.764~769 (2008)
9. Kim J, "p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells", FEBS Lett, 581, pp.3795~3799 (2007)
10. Zhang CO, "APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis", Urol, 5, pp.7~ (2005)
11. Keay S, "Normalization of proliferation and tight junction formation in bladder epithelial cells from patients with interstitial cystitis", painful bladder syndrome by d-proline and d-pipecolic acid derivatives of antiproliferative factor, 2011, pp.77, 421~430
12. Tseng-Rogenski S, "Interleukin-8 is essential for normal urothelial cell survival", Am J Physiol Renal Physiol, 297, pp.F816~F821 (2009)
13. Graham E, "Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis", Curr Urol Rep, 7, pp.440~446 (2006)
14. Parsons CL, "The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis", overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain, 2011, pp.107, 370~375
15. Jhang JF, "Characteristics and electrocauterization of Hunner’s lesions associated with bladder pain syndrome", Urol Sci, 24, pp.51~55 (2013)
16. Gamper M, "Local immune response in bladder pain syndrome", interstitial cystitis ESSIC type 3C, 2013, pp.24, 2049~2057
17. Homma Y, "Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis", J Urol, 190, pp.1925~1931 (2013)
18. Colaco M, "Correlation of gene expression with bladder capacity in interstitial cystitis", bladder pain syndrome, 2014, pp.192, 1123~1129
19. Ogawa T, "CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis", J Urol, 183, pp.1206~1212 (2010)
20. Lee J, "Is interstitial cystitis an allergic disorder?: a case of interstitial cystitis treated successfully with anti-IgE", Int J Urol, 13, pp.631~634 (2006)
21. Parsons CL, "The role of the urinary epithelium in the pathogenesis of interstitial cystitis", prostatitis, Urology, pp.2007, 69(4 Suppl)[DOI]
22. Bouchelouche K, "Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis", J Urol, 166, pp.2121~2125 (2001)
23. Kim J, "Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation", BJU Int, 103, pp.541~546 (2009)
24. Shie JH, "Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis", painful bladder syndrome, 2012, pp.79, 484.e7~484.e13
25. Murray E, "Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder", J Urol, 172(6Pt 1), pp.2434~2439 (2004)
26. Oddiah D, "Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder", Neuroreport, 9, pp.1455~1458 (1998)
27. Chuang YC, "The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor", J Urol, 165, pp.975~979 (2001)
28. Lamb K, "Increased nerve growth factor expression triggers bladder overactivity", J Pain, 5, pp.150~156 (2004)
29. Lee CL, "Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls", BJU Int, 112, pp.1156~1162 (2013)
30. Liu HT, "Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis", bladder pain syndrome, 2012, pp.80, 225.e13~225.e18
31. van Roy F, "The cell-cell adhesion molecule E-cadherin", Cell Mol Life Sci, 65, pp.3756~3788 (2008)
32. Chuang FC, "Increased urothelial cell apoptosis and chronic inflammation are associated with recurrent urinary tract infection in women", PLoS One, 8, pp.e63760~ (2013)
33. Slobodov G, "Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis", J Urol, 171, pp.1554~1558 (2004)
34. Min G, "Structural basis of urothelial permeability barrier function as revealed by Cryo-EM studies of the 16 nm uroplakin particle", J Cell Sci, 116(Pt 20), pp.4087~4094 (2003)
35. Byrne DS, "The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis", J Urol, 161, pp.1786~1790 (1999)
36. Hurst RE, "Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis", Urology, 69(4 Suppl), pp.17~23 (2007)
37. Van De Merwe JP, "Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis", BJU Int, 85, pp.995~999 (2000)
38. Saban R, "Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients", Am J Physiol Renal Physiol, 295, pp.F1613~F1623 (2008)
39. Lee JD, "Increased expression of hypoxia-inducible factor-1α and vascular endothelial growth factor associated with glomerulation formation in patients with interstitial cystitis", Urology, 78, pp.971.e11~971.e15 (2011)
40. Tamaki M, "Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors", J Urol, 172, pp.945~948 (2004)
41. Peng CH, "Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis", Urology, 82, pp.1452.e1~1452.e6 (2013)
42. Kuo HC, "Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis", Urol Int, 75, pp.170~174 (2005)
43. Giannantoni A, "Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study", Eur Urol, 49, pp.704~709 (2006)
44. Liu HT, "Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis", Urology, 70, pp.463~468 (2007)
45. Lee CL, "Long-term efficacy and safety of repeated intravescial onabotulinumtoxinA injections plus hydrodistention in the treatment of interstitial cystitis", bladder pain syndrome, 2015, pp.7, 4283~4293
46. Shie JH, "Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis", bladder pain syndrome, 2013, pp.111, 638~646
47. Elbadawi A, "Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis", Urology, 49(5A Suppl), pp.14~40 (1997)
48. Steers WD, "Interstitial cystitis", pp.67~75 (1997), Lippincott-Raven Publishers
49. Lowe EM, "Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis", Br J Urol, 79, pp.572~577 (1997)
50. Sun Y, "Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis", Am J Physiol Cell Physiol, 290, pp.C27~C34 (2006)
51. Wesselmann U, "Interstitial cystitis: a chronic visceral pain syndrome", Urology, 57(6 Suppl 1), pp.32~39 (2001)
52. Steers WD, "Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders", Nat Clin Pract Urol, 3, pp.101~110 (2006)
53. Cui M, "Subcutaneous administration of botulinum toxin A reduces formalin-induced pain", Pain, 107, pp.125~133 (2004)
54. Seki S, "Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats", J Urol, 168, pp.2269~2274 (2002)
55. Lai HH, "Segmental hyperalgesia to mechanical stimulus in interstitial cystitis", bladder pain syndrome:evidence of central sensitization, 2014, pp.191, 1294~1299
56. Wiseman OJ, "The role of the human bladder lamina propria myofibroblast", BJU Int, 91, pp.89~93 (2003)
57. Avelino A, "Vanilloid receptor 1 expression in the rat urinary tract", Neuroscience, 109, pp.787~798 (2002)
58. Dupont MC, "Histological and neurotrophic changes triggered by varying models of bladder inflammation", J Urol, 166, pp.1111~1118 (2001)
59. Kuo HC, "Urinary nerve growth factor levels in urinary tract diseases with or without frequency urgency symptoms", Low Urin Tract Symptoms, 2, pp.88~94 (2010)
60. Liu HT, "Urinary nerve growth factor level is increased in patients with interstitial cystitis", bladder pain syndrome and decreased in responders to treatment, 2009, pp.104, 1476~1481
61. Wilkinson DR, "Urinary and serologic markers forinterstitial cystitis: an update", Curr Urol Rep, 7, pp.414~422 (2006)
62. Peters KM, "Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette-Guérin treat interstitial cystitis by altering the immune profile in the bladder?", Urology, 54, pp.450~453 (1999)
63. Erickson DR, "Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis?", J Urol, 173, pp.93~97 (2005)
64. Smaldone MC, "Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis", Urology, 73, pp.421~426 (2009)
65. Bouchelouche K, "Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells", J Urol, 171, pp.462~466 (2004)
66. Lintomen L, "Human eosinophil adhesion and degranulation stimulated with eotaxin and RANTES in vitro: lack of interaction with nitric oxide", BMC Pulm Med, 8, pp.13~ (2008)
67. Muessel MJ, "CCL11and GM-CSF differentially use the Rho GTPase pathway to regulate motility of human eosinophils in a three-dimensional microenvironment", J Immunol, 180, pp.8354~8360 (2008)
68. Tyagi P, "Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis", J Urol, 187, pp.2243~2248 (2012)
69. Chung SD, "Elevation of serum c-reactive protein in patients with OAB and IC", BPS implies chronic inflammation in the urinary bladder, 2011, pp.30, 417~420
70. Liu HT, "Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease", PLoS One, 7, pp.e44687~ (2012)
71. Jiang YH, "Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis", bladder pain syndrome, 2013, pp.8, e76779~
72. Messing EM, "Interstitial cystitis: early diagnosis, pathology, and treatment", Urology, 12, pp.381~392 (1978)
73. Negrete HO, "Permeability properties of the intact mammalian bladder epithelium", Am J Physiol, 271(4 Pt 2), pp.F886~F894 (1996)
74. Zeidel ML, "Low permeabilities of apical membranes of barrier epithelia:what makes watertight membranes watertight?", Am J Physiol, 271(2 Pt 2), pp.F243~F245 (1996)
75. Tzan CJ, "Effect of protamine sulfate on the permeability properties of the mammalian urinary bladder", J Membr Biol, 133, pp.227~242 (1993)
76. Lewis SA, "Modulation of epithelial permeability by extracellular macromolecules", Physiol Rev, 75, pp.561~589 (1995)
77. Lavelle JP, "Urothelial pathophysiological changes in feline interstitial cystitis:a human model", Am J Physiol Renal Physiol, 278, pp.F540~F553 (2000)
78. Lavelle J, "Bladder permeability barrier: recovery from selective injury of surface epithelial cells", Am J Physiol Renal Physiol, 283, pp.F242~F253 (2002)
79. Huang LK, "Evaluation of the extent of ketamine-induced uropathy: the role of CT urography", Postgrad Med J, 90, pp.185~190 (2014)
80. Bouchelouche K, "Recent developments in the management of interstitial cystitis", Curr Opin Urol, 13, pp.309~313 (2003)
81. Hanno PM, "Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases", Interstitial Cystitis Association scientific conference on interstitial cystitis, 2001, pp.57(6 Suppl 1), 2~6
82. Hanno PM, "AUA guideline for the diagnosis and treatment of interstitial cystitis", bladder pain syndrome, 2011, pp.185, 2162~2170
83. van de Merwe JP, "Diagnostic criteria, classification, and nomenclature for painful bladder syndrome", interstitial cystitis: an ESSIC proposal, 2008, pp.53, 60~67
84. Hanno P, "Bladder Pain Syndrome Committee of the International Consultation on Incontinence", Neurourol Urodyn, 29, pp.191~198 (2010)
85. Gillenwater JY, "Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987", J Urol, 140, pp.203~206 (1988)
86. Hanno PM, "The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study", J Urol, 161, pp.553~557 (1999)
87. Denson MA, "Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis", J Urol, 164, pp.1908~1911 (2000)
88. Jiang YH, "Revisiting the role of potassium sensitivity testing and cystoscopic hydrodistention for the diagnosis of interstitial cystitis", PLoS One, 11, pp.e0151692~ (2016)
89. Macdiarmid SA, "Diagnosis of interstitial cystitis", painful bladder syndrome in patients with overactive bladder symptoms, 2007, pp.9, 9~16
90. Keller JJ, "Comorbidities of bladder pain syndrome", interstitial cystitis: a population-based study, 2012, pp.110(11 Pt C), E903~E909
91. Martínez-Martínez LA, "Fuentes-Iniestra M, Martínez-Lavín M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies", J Clin Rheumatol, 20, pp.146~150 (2014)
92. Warren JW, "Before the onset of interstitial cystitis", bladder pain syndrome, the presence of multiple non-bladder syndromes is strongly associated with a history of multiple surgeries, 2014, pp.76, 75~79
93. Nickel JC, "Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis", bladder pain syndrome, 2015, pp.193, 138~144
94. Clemens JQ, "Temporal ordering of interstitial cystitis", bladder pain syndrome and non-bladder conditions, 2012, pp.80, 1227~1231
95. Fuoco MB, "Multiple sensitivity phenotype in interstitial cystitis", bladder pain syndrome, 2014, pp.8, E758~E761
96. Hall SA, "The relationship of common medical conditions and medication use with symptoms of painful bladder syndrome: results from the Boston area community health survey", J Urol, 180, pp.593~598 (2008)
97. Peters KM, "Characterization of a clinical cohort of 87 women with interstitial cystitis", painful bladder syndrome, 2008, pp.71, 634~640
98. Bassaly R, "Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis", Int Urogynecol J, 22, pp.413~418 (2011)
99. Weinstock LB, "Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms", Dig Dis Sci, 53, pp.1246~1251 (2008)
100. Rudick CN, "Organ cross talk modulates pelvic pain", Am J Physiol Regul Integr Comp Physiol, 293, pp.R1191~R1198 (2007)

관련 논문AI추천